Skimune® can predict first-in-man hypersensitivity or adverse immune reactions to ...
By Alcyomics Ltd. based in Newcastle Upon Tyne, UNITED KINGDOM.
Bellerophon Therapeutics is developing the INOpulse delivery system for the treatment of patients with pulmonary hypertension associated with sarcoidosis ...
By Bellerophon Therapeutics based in Warren, NEW JERSEY (USA).
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you